January 26-28, 2022 Virtual Conference
![]() |
![]() |
![]() |
![]() |
P-101 | GUT MICROBIOTA IMPACT ON ANGOLAN CHILDREN WITH SICKLE CELL DISEASE | Miguel Brito | ![]() |
![]() |
|||
P-102 | PLASMA FREE HEMOGLOBIN AND REACTIVE OXYGEN SPECIES IN SICKLE CELL ANAEMIA PATIENTS UNDER HYDROXYUREA AND GLUTAMINE THERAPY | Anastasios Kriebardis | ![]() |
![]() |
|||
P-103 | THE ABNORMAL PRESENCE OF MITOCHONDRIA IN CIRCULATING SCD RED BLOOD CELLS ASSOCIATED WITH STRESS ERYTHROPOIESIS | Angela Rivers | ![]() |
![]() |
|||
P-104 | BASE EDITING REPAIRS THE HBE MUTATION RESTORING THE PRODUCTION OF NORMAL GLOBIN CHAINS IN SEVERE HBE/BETA-THALASSEMIA PATIENT HAEMATOPOIETIC STEM AND ERYTHROID CELLS | Mohsin Badat | ![]() |
![]() |
|||
P-105 | BLOOD MICROVESICLES AS BIOMARKERS TO PREDICT VASO-OCCLUSIVE CRISIS IN SICKLE CELL ANEMIA | Mariem Chebbi | ![]() |
![]() |
|||
P-106 | EARLY PREVENTIVE DIAGNOSIS OF HEMOLYTIC ANEMIA IN SICKLE CELL PATIENTS BY DETECTING THE TRIGGERING OF ERYPTOSIS. | Khouloud Khalfaoui | ![]() |
![]() |
|||
P-107 | A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MITAPIVAT IN PATIENTS WITH SICKLE CELL DISEASE | Swee Lay Thein | ![]() |
![]() |
|||
P-108 | ASSESSMENT OF HEALTHCARE WORKERS KNOWLEDGE AND RESOURCE AVAILABILITY FOR CARE OF SICKLE CELL DISEASE AT HEALTH FACILITIES IN DAR ES SALAAM, TANZANIA | Agnes Jonathan | ![]() |
![]() |
|||
P-109 | CLINICAL CATEGORIZATION OF CHILDREN WITH SICKLE CELL DISEASE USING SEVERITY SCORE AT A TERTIARY CARE CENTER | Swaroop Kumar | ![]() |
![]() |
|||
P-110 | CLINICAL CHARACTERISTICS OF COVID-19 IN SICKLE CELL DISEASE (SCD) PATIENTS | Hafiz Malhan | ![]() |
![]() |
|||
P-111 | COVID-19 IN PATIENTS WITH THALASSEMIA AND SICKLE CELL DISEASE: A SINGLE CENTER EXPERIENCE | Maria Dimopoulou | ![]() |
![]() |
|||
P-112 | ENERGIZE AND ENERGIZE-T: TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES OF MITAPIVAT IN ADULTS WITH NON--TRANSFUSION-DEPENDENT OR TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA | Kevin Kuo | ![]() |
![]() |
|||
P-113 | INCIDENCE OF HAEMOGLOBINOPATHY IN SLOVAKIA | Viera Fábryová | ![]() |
![]() |
|||
P-114 | NEWBORN SCREENING FOR HAEMOGLOBINOPATHIES IN BIDA, NORTH CENTRAL NIGERIA. | Olumuyiwa Folayan | ![]() |
![]() |
|||
P-115 | REAL-WORLD DATA ON THE EFFICACY OF PHARMACEUTICAL-GRADE L-GLUTAMINE IN PREVENTING SICKLE CELL DISEASE-RELATED ACUTE COMPLICATIONS AND HEMOLYSIS IN PEDIATRIC AND ADULT PATIENTS. | Mohamed Yassin | ![]() |
![]() |
|||
P-116 | THE IMPACT OF COVID19 PANDEMIC ON SICKLE CELL MANAGEMENT: EXPERIENCE OF A SINGLE PEDIATRIC CENTER | Maria Vousvouki | ![]() |
![]() |
|||
P-117 | THE INTERNATIONAL HAEMOGLOBINOPATHY RESEARCH NETWORK (INHERENT): AN INTERNATIONAL INITIATIVE TO STUDY THE ROLE OF GENETIC MODIFIERS IN HAEMOGLOBINOPATHIES | Petros Kountouris | ![]() |
![]() |
|||
P-118 | THE ROLE OF HEMOGLOBIN AND HEMOLYSIS ON TRANSCRANIAL DOPPLER VELOCITIES IN CHILDREN WITH SICKLE CELL DISEASE: DATA FROM A NATURAL HISTORY COHORT | Raffaella Colombatti | ![]() |
![]() |
|||
P-119 | TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1B CROSSWALK-A TRIAL EVALUATING THE SAFETY OF CROVALIMAB FOR THE MANAGEMENT OF ACUTE UNCOMPLICATED VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) | Himika Patel | ![]() |
![]() |
|||
P-120 | TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) | Julia Ramos | ![]() |
![]() |
|||
P-121 | PREVALENCE OF VERTEBRAL COMPRESSION FRACTURE AND HYPOVITAMINOSIS D IN CHILDREN WITH THALASSEMIA MAJOR | Ludi Dhyani Rahmartani | ![]() |
![]() |
|||
P-122 | DEEP LEARNING-BASED ALGORITHM FOR AUTOMATIC SPLEEN LENGTH MEASUREMENT | Zhen Yuan | ![]() |
![]() |
|||
P-123 | A SYSTEMATIC REVIEW OF THE BARRIERS TO UPTAKE AND ADHERENCE TO HYDROXYCARBAMIDE FROM THE PERSPECTIVE OF CHILDREN AND ADULTS WITH SICKLE CELL DISEASE, PARENTS AND CLINICIANS. | CLARE CLARK | ![]() |
![]() |
|||
P-124 | EFFICACY OF NON-PHARMACOLOGICAL INTERVENTIONS TO REDUCE PAIN IN CHILDREN WITH SICKLE CELL DISEASE: A SYSTEMATIC REVIEW | Caroline Vuong | ![]() |
![]() |
|||
P-126 | HEALTH LITERACY AND DISEASE KNOWLEDGE IN YOUNG PERSONS WITH SICKLE CELL DISEASE | Bonaventure Ikediashi | ![]() |
![]() |
|||
P-127 | HEALTHCARE RESOURCE UTILIZATION PATTERNS AND RELATED COSTS IN PATIENTS WITH SICKLE CELL DISEASE IN NORTH LEBANON- A REAL-WORLD EXPERIENCE | Adlette Inati | ![]() |
![]() |
|||
P-128 | ITHANET: AN INFORMATION AND DATABASE COMMUNITY PORTAL FOR HAEMOGLOBINOPATHIES | Anna Minaidou | ![]() |
![]() |
|||
P-129 | NARRATING SICKLE CELL DISEASE: THE EXPERIENCES OF PATIENTS AND CARGIVERS | Luigi Reale | ![]() |
![]() |
|||
P-130 | PROVIDING ADEQUATE HEALTHCARE TO PEOPLE WITH HEMOGLOBINOPATHIES DURING THE PANDEMIC (COVID-19) | Sophia Delicou | ![]() |
![]() |
|||
P-131 | REAL-TIME VACCINATION IMPACTS IN SICKLE CELL DISEASE: A REAL-WORLD PATIENT CASE STUDY FOR INFLUENZA AND COVID-19 VACCINATION | Kim Summers | ![]() |
![]() |
|||
P-132 | REVIEW OF THE INTEGRATED PSYCHOLOGICAL INPUT AT ANNUAL REVIEW CLINICS FOR PEOPLE WITH SICKLE CELL | Will Tamblyn | ![]() |
![]() |
|||
P-133 | TEENAGE WELL-BEING -- A VIRTUAL SUPPORT GROUP | Lesley McCarthy | ![]() |
![]() |
|||
P-134 | THE AREAL PROJECT: A VIRTUAL REALITY APPLICATION TO SUPPORT THE THERAPEUTIC EXPERIENCE AND THERAPY EDUCATION OF ADULT PATIENTS WITH THALASSEMIA AND SICKLE CELL DISEASE | Raffaella Colombatti | ![]() |
![]() |
|||
P-135 | THE CLINGEN HEMOGLOBINOPATHY VARIANT CURATION EXPERT PANEL | Coralea Stephanou | ![]() |
![]() |
|||
P-136 | THE UPTAKE OF VACCINATIONS IN ADULTS WITH SICKLE CELL DISEASE RECEIVING CARE AT THE CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST | Joanna Kucharczak | ![]() |
![]() |
|||
P-137 | WHATS IN A NAME? PATIENTS WANT US TO RETHINK SICKLE CELL DISEASE | Claire Otasowie | ![]() |
![]() |
|||
P-138 | WHITE PAPER: ASSESSMENT OF INTERNATIONAL SICKLE CELL DISEASE GUIDELINES IN HIGH-, MIDDLE-, AND LOW-INCOME COUNTRIES | Nidhi Suthar | ![]() |
![]() |
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|